PHARMACEUTICAL COMPOSITION FOR TREATING FLT3 MUTATION-POSITIVE CANCER, FLT3 MUTANT INHIBITOR, AND USE OF SAID PHARMACEUTICAL COMPOSITION AND SAID INHIBITOR
The present invention addresses the problem of providing: a pharmaceutical composition for treating FLT3 mutation-positive cancer an FLT3 mutant inhibitor and a use of the pharmaceutical composition and the inhibitor. Provided are: a pharmaceutical composition for treating FLT3 mutation-positive cancer, which contains, as an active ingredient, a compound represented by general formula [1] or a salt thereof an FLT3 mutant inhibitor an anti-cancer agent a method for predicting the therapeutic effect of the administration of a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof in a subject, said method comprising a step of detecting the presence or absence of an FLT3 mutation a method for selecting a subject to whom a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof can be applied, said method comprising a step of detecting the presence or absence of an FLT3 mutation and a method for determining whether or not a pharmaceutical composition containing a compound represented by general formula [1] or a salt thereof can be administered to a subject, said method comprising a step of detecting the presence or absence of an FLT3 mutation.La présente invention vise à fournir: une composition pharmaceutique pour le traitement de cancer positif à mutation FLT3 un inhibiteur mutant de FLT3 et une utilisation de la composition pharmaceutique et linhibiteur. A cet effet, linvention concerne: une composition pharmaceutique pour le traitement de cancer positif à la mutation FLT3, qui contient, en tant que principe actif, un composé représenté par la formule générale [1] ou un sel de celui-ci un inhibiteur mutant de FLT3 un agent anticancéreux un procédé pour la prédiction de leffet thérapeutique de ladministration dune composition pharmaceutique contenant un composé représenté par la formule générale [1] ou un sel de celui-ci chez un sujet, ledit procédé comprenant une étape de dét
